Karuna Therapeutics, Inc. (KRTX) Financials

KRTX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 1.3 billion 82.0 million
2023-09-30 1.4 billion 62.8 million
2023-06-30 1.5 billion 52.5 million
2023-03-31 1.5 billion 28.0 million

KRTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -111.9 million 22.8 million
2023-09-30 -110.6 million 18.3 million
2023-06-30 -64.9 million 18.0 million
2023-03-31 -101.3 million 15.5 million

KRTX Net Income

No data available :(

KRTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 1.3 billion - 16.7 million
2023-09-30 1.3 billion - 15.6 million
2023-06-30 1.4 billion - 15.8 million
2023-03-31 1.5 billion - 4.8 million

KRTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 37.8 million
2023-09-30 37.7 million
2023-06-30 37.5 million
2023-03-31 34.8 million

KRTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 799000 82.2 million 47.4 million -
2023-09-30 629000 104.0 million 32.3 million -
2023-06-30 775000 92.5 million 27.4 million -
2023-03-31 714000 85.5 million 24.3 million -

KRTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -
2023-09-30 - 458000
2023-06-30 - 469000
2023-03-31 654000 327000

KRTX

Price: $329.83

52 week price:
158.38
329.83

Earnings Per Share: -10.94 USD

P/E Ratio: -29.07

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 180800

Market Capitalization: 12.1 billion

Links: